Coenzyme Q10 in neurodegenerative disorders: Potential benefit of CoQ10 supplementation for multiple system atrophy

doi:10.5316/wjn.v4.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8999)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

556

WORD

337

HTML

6159

Figures (1-1)

160

Tables (1-1)

142

Sum=7354

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

953

Download

692

Sum=1645

Mar 28, 2014 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Neurology

ISSN

2218-6212

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Neurol. Mar 28, 2014; 4(1): 1-6
Published online Mar 28, 2014. doi: 10.5316/wjn.v4.i1.1

Open in New Tab Full Size Figure Download Figure

Figure 1 Coenzyme Q10 biosynthesis pathway. Enzyme and human gene symbols are shown in italics. HMG-CoA: 3-hydroxy-3-methylglutaryl coenzyme A; PDSS: Prenyldiphosphate synthase subunit; PP: Pyrophosphate; PHB: Para-hydroxy-benzoate; CoQ10: Coenzyme Q10; CABC: Chaperone-activity of bc1.

Citation: Takahashi H, Shimoda K. Coenzyme Q10 in neurodegenerative disorders: Potential benefit of CoQ10 supplementation for multiple system atrophy. World J Neurol 2014; 4(1): 1-6
URL: https://www.wjgnet.com/2218-6212/full/v4/i1/1.htm
DOI: https://dx.doi.org/10.5316/wjn.v4.i1.1